The Japanese Journal of Urology
Online ISSN : 1884-7110
Print ISSN : 0021-5287
ISSN-L : 0021-5287
CLINICAL STUDY OF LONG GRAFT SURVIVAL IN RENAL TRANSPLANTATION RECIPIENTS
Ichiro TakeuchiTetsuo HiranoKimihiko MoriyaTakanori SakutaMasaki TogashiNobuo OhashiShinji FujitaOsamu Nounaka
Author information
JOURNAL FREE ACCESS

1998 Volume 89 Issue 6 Pages 609-613

Details
Abstract

(Background) A total of 110 patients, in whom kidneys from 95 living related and 15 cadaver donor, had experienced renal transplantation between February 1985 and October 1996 in our clinic. This study was conducted to evaluate the influence of the various pre-operative factors to the graft survivals and clinical course of patients in living related renal transplantation.
(Methods) In 95 recipients, 17 adult patients had long term graft survivals over 5 years including 6 recurrent or denovo nephritis without chronic allografts nephropathy. Eight failed to graft loss attributed to chronic allografts nephropathy diagnosed within 5 years. Retrospective analysis were performed to elucidate the differences of these recipients.
(Results) Donors of long graft survival recipients were younger (49.1±12.1 v. s. 58.9±10.2) and had a better renal function evaluated by preoperative creatinine clearance in living related donors (115.5±37.0 v. s. 79.7±22.0l/day). Graft long survival recipients had experienced less frequencies of acute rejection within 6 months (0.53±0.62: 8 patients, 9 times) compared with chronic allografts nephropathy recipients (1.00±0.53: 7 patients, 8 times). Long graft survival recipients had better responses to the antirejection therapy. Additionally acute rejection over 6 months were experienced only in chronic allografts nephropathy recipients. Higher serum creatinine level was revealed in recipients with chronic allografts nephropathy at 1 year after transplantation (1.27±0.27 v. s. 1.88±0.42 mg/dl).
(Conclusions) We concluded that donor age and renal function are related to the graft long survival as background factors. Long graft survival recipients had less frequency of acute rejection and good response to the antirejection therapy. In recipients with of acute rejection and good response to the antirejection therapy. In recipients with chronic allografts nephropathy, serum cretine level had already increased gradually within 1 year.

Content from these authors
© Japanese Urological Association
Previous article Next article
feedback
Top